Les publications HAL U835

2018

24 publication(s) :

Remarque : Seuls les 15 premiers auteurs sont affichés.

Articles avec comité de lecture de revues internationales

: 1 -
: Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii
: Gregory A. Knauf, Ashley L. Cunningham, Misha I. Kazi, Ian M. Riddington, Alexander A. Crofts, Vincent Cattoir, M. Stephen Trent, Bryan W. Davies
: mBio, 2018, 9 (1), pp.e02394-17. ⟨10.1128/mBio.02394-17⟩.
: DOI : https://doi.org/10.1128/mBio.02394-17
: Pubmed : 29437928

: 2 -
: Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli
: M Berleur, F Guérin, L Massias, F. Chau, J Poujade, V Cattoir, B Fantin, V de Lastours
: Journal of Antimicrobial Chemotherapy, 2018, 73 (11), pp.3074-3080.
: DOI : https://doi.org/10.1093/jac/dky283
: Pubmed : 30085154

: 3 -
: Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure observations in an in vivo mouse model of prosthetic vascular material infections
: Rym Boudjemaa, Karine K. Steenkeste, Cédric Jacqueline, Romain Briandet, Jocelyne Caillon, David Boutoille, Virginie Le Mabecque, Pierre Tattevin, Marie-Pierre Fontaine-Aupart, Matthieu Revest
: Journal of Antimicrobial Chemotherapy, 2018, 73 (9), pp.2418-2421. ⟨hal-01834453v2⟩
: DOI : https://doi.org/10.1093/jac/dky205
: Pubmed : 29901764

: 4 -
: Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
: Charles Burdet, Paul Loubet, Vincent Le Moing, William Vindrios, Marina Esposito-Farèse, Morgane Linard, Tristan Ferry, Laurent Massias, Pierre Tattevin, Michel Wolff, François Vandenesch, Nathalie Grall, Caroline Quintin, France Mentré, Xavier Marie Duval et al.
: BMJ Open, 2018, 8 (8), pp.e023151.
: DOI : https://doi.org/10.1136/bmjopen-2018-023151
: Pubmed : 30173161

: 7 -
: Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia? Aspergillose cérébrale : une infection opportuniste émergente chez les patients traités par ibrutinib pour leucémie lymphoïde chronique ?
: E Gaye, Audrey Le Bot, Jean-Philippe Talarmin, Ronan Le Calloch, Sorya Belaz, Mathieu Dupont, Pierre Tattevin
: Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?. Médecine et Maladies Infectieuses, 2018, 48 (4), pp.294-297.
: DOI : https://doi.org/10.1016/j.medmal.2018.01.003
: Pubmed : 29402474

: 8 -
: Evaluation of the Rapid Polymyxin NP test and its industrial version for the detection of polymyxin-resistant Enterobacteriaceae
: Aurélie Jayol, Nicolas Kieffer, Laurent Poirel, François Guérin, Deniz Güneser, Vincent Cattoir, Patrice Nordmann
: Diagnostic Microbiology and Infectious Disease, 2018, 92 (2), pp.90-94.
: DOI : https://doi.org/10.1016/j.diagmicrobio.2018.05.006
: Pubmed : 29895404

: 9 -
: Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe Towards a common nomenclature
: Jennifer K Bender, Vincent Cattoir, Kristin Hegstad, Ewa Sadowy, Teresa M Coque, Henrik Westh, Anette M Hammerum, Kirsten Schaffer, Karen Burns, Stephen Murchan, Carla Novais, Ana R Freitas, Luísa Peixe, Maria del Grosso, Annalisa Pantosti et al.
: Drug Resistance Updates, 2018, 40, pp.25-39.
: DOI : https://doi.org/10.1016/j.drup.2018.10.002
: Pubmed : 30447411

: 10 -
: No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015
: M. Lachatre, Matthieu Mechain, M. Etienne, P. Gautret, S. Matheron, M. Nahon, H. Coignard-Biehler, Denis Malvy, X. Duval, P. Tattevin
: Clinical Microbiology and Infection, 2018, 24 (3), pp.310-311.
: DOI : https://doi.org/10.1016/j.cmi.2017.09.004
: Pubmed : 28899839